It may be time to schedule an appointment with your horse’s veterinarian. The first shipments of Adequan® IM went out last week.
Despite the initial push, Luitpold Animal Health reports the product supply remains limited and will not meet the market’s demand. The company said in a statement that it is working diligently to release additional product, although a time frame is not currently known.
Product shortages were due to renovations and upgrades to Luitpold’s Shirley, NY manufacturing facility after the company received a warning letter from the FDA in 2011.
Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and / or traumatic joint dysfunction and associated lameness in horses.
If you have questions, you can contact their customer service at 800-458-0163.